+
Site Tour

EACTS 2022 Symposium: When can Tendyne TMVR be a relevant substitute for on-pump MVR?

Rudiger Lange’s presentation from a symposium held at EACTS 2022: From established to advanced therapies and technologies that change lives.

Related Videos

AV Valves Summit 2024 | Closing of Day 1

Mechanical Heart Valve Patient Story: Sadie

Now you've got Navitor.
Future ready.

TAVI Summit - Cardiac imaging

Navigating the Anatomy | Tricuspid focus

EuroPCR 2023: Vascular access

PCRLV 2022: Tricuspid valve intervention

Epic™ HCP testimonial

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

CONNEXT


HUB
RELATED RESOURCES

ACC 2023: COAPT™ trial

bRIGHT study

Epic Mitral – 10-Year Clinical Outcomes

EuroEcho 2021: MR Treatment (Evidence)

CONNEXT


LIVE
RELATED EVENTS

MitraClip - AVVS 1 year 1 minute Mitral - Video

TAVI 2023: The next level

AV VALVES 2023: TA, TF in TMVR

TAVI Summit - Live case from Berlin

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline